A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

http://www.wikidata.org/entity/Q33842644

about

Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology Immunology in wild nonmodel rodents: an ecological context for studies of health and disease The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice Fcγ Receptors in Solid Organ Transplantation Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes FcγRIIB and autoimmunity.Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Copy number, linkage disequilibrium and disease association in the FCGR locus.Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice.FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy.FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis Functional Fcgamma receptor polymorphisms are associated with human allergy.High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.Characterization of the biological processes shaping the genetic structure of the Italian population.Evolutionary history of copy-number-variable locus for the low-affinity Fcγ receptor: mutation rate, autoimmune disease, and the legacy of helminth infection.Testing the role of the FcγRIIB immunoreceptor tyrosine-based inhibitory motif in regulation of the B cell immune response.Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.Possible influence of resistance to malaria in clinical presentation of rheumatoid arthritis: biological significance of natural selection.Distribution of FcγR gene polymorphisms among two sympatric populations in Mali: differing allele frequencies, associations with malariometric indices and implications for genetic susceptibility to malaria Regulation of allograft survival by inhibitory FcγRIIb signaling Comprehensive Assessment of the Association between FCGRs polymorphisms and the risk of systemic lupus erythematosus: Evidence from a Meta-Analysis Toll-like receptor 7 mediates early innate immune responses to malaria.LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity.Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus-associated polymorphism FcγRIIB-T232.FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.FcγRIIB: a modulator of cell activation and humoral tolerance.Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.B-cell regulation and its application to transplantation.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Targeting B cells and autoantibodies in the therapy of autoimmune diseases.B-cell biomarkers in transplantation--from genes to therapy.Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?Pathway deregulation and expression QTLs in response to Actinobacillus pleuropneumoniae infection in swine.Regulatory B cells mediate tolerance to apoptotic self in health: implications for disease.

P2860

Q24632121-9461EA22-412D-4301-B9A0-AFF1120879F4 Q26782139-E492A714-0CF8-46F1-9E70-4077130138B3 Q27012980-44EC67BC-4D38-4463-89E7-DE729D6CDFB9 Q27321708-ED168947-E366-4775-BB0A-4BBF677F7503 Q28076012-291D5F33-352A-4DD7-B81D-9D9CCA6CB816 Q30612568-69A0668E-8D0D-45D6-B2E5-D9CD75C9DFF2 Q30981881-06FD8862-96A8-48BD-BE79-C06D93597DF0 Q31083477-5C06BC9E-B895-45D3-A42A-772D2C8E1CD0 Q33417296-572D9C6E-020E-4E7A-9B12-0D602EBA234C Q33686907-8213DAF1-28E8-43DE-9D4B-330B85C2B520 Q33690722-50C5BC17-694B-4571-B807-CD612418AAE7 Q33821137-B46B112D-F978-4F04-8CBE-E27B5F7110BC Q34013523-1F56E7A9-EA6D-4180-8341-5ACD14122C6A Q34106643-CEB7772C-7D01-4FDA-AD5F-50C1BA857595 Q34509018-0381E1F8-0658-4A56-B8A5-694804361EA8 Q34674784-E8F4B09A-A062-4E48-8008-4AD03E2FC89C Q34752151-FAFC0DBF-522F-4108-B2D6-38C242B39D66 Q35106837-28C551F5-9220-4B4F-B9C7-1D584D2A56B9 Q35624357-676A4EF2-BBAF-4270-9DBC-4ABDB6308825 Q35836782-2847B25F-F2C6-4467-92A6-77F397CFD11E Q36017054-D370E256-C08D-4DDA-999D-165DAE520563 Q36082324-8921F273-E34A-4B83-9B71-C5F8751CD854 Q36409027-C6B75D73-E0F3-4494-AD4C-D2BC8EA292C7 Q36417884-3C2C3A86-BFB4-4719-B20E-B7102BA6AF6A Q36476336-D05E1E86-D3D7-4AB2-8235-D8C578AA17CD Q36708983-1EEFEC97-9858-49A5-82F0-1D951BB97840 Q37188962-56ABDC83-B871-4903-A11D-1458A5023BF7 Q37336051-8CCB0180-59B8-4ECF-AD61-A6EB6AC7910F Q37381383-071E02B8-8C82-46AF-BD05-802823BD6CC0 Q37415229-34A340E8-D0BD-4F13-8A72-4365CED2F1E1 Q37736263-EFA83A6A-FB1A-415E-8E93-53E6A551643A Q37990547-DFA6CB16-A56F-4B97-9000-B53A592C59A0 Q38001400-631CD431-1C43-407D-8B29-635951CC2F10 Q38126085-17EBF713-4F3C-46C6-89CB-37F8788FC7E5 Q38182646-147A95B6-9245-46CB-B362-200F95E29D39 Q38207937-55320C31-9357-4A75-AD74-F00B1CEC681C Q38334458-061C87DC-5220-46F8-BD9B-1C18EE0CE0C0 Q38344833-18306139-C056-43BB-A4B7-EE11305EA98C Q38473920-AC402468-AF22-451C-AE1B-8E12364C56E8 Q38573630-5F3A00AA-25D2-41F2-B58A-602FE46C3552

P2860

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

http://www.wikidata.org/entity/Q33842644

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@ast

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@en

type

label

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@ast

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@en

prefLabel

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@ast

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@en

P1433

Q33842644-BC1FD16A-88E1-45E2-932E-81CCE3F10E97

P1476

Q33842644-44EEDFC6-09C6-4AB7-B7E9-88B0F16E3566

P2093

Q33842644-0D3B8F67-B40A-4C05-AB2F-266CE49F5CA0

Q33842644-40C0EB0E-208F-40ED-9EF6-A0B1C2D206EF

Q33842644-71E240BA-C83B-47A1-89E9-C122E0077ACC

Q33842644-73791137-D51E-4FBD-9046-B5FF58D2AA54

Q33842644-7C1ADE91-533F-4955-B572-F40D078BF4A9

Q33842644-9F2C2920-5114-435A-9F35-755FF806CD1B

Q33842644-AA3D8C95-BA88-401D-AF14-D9C2BDBBA303

Q33842644-B16B7919-055D-4814-8797-1C2BF89665FB

P2860

Q33842644-013D4B00-E78B-4972-B299-DDB2F6B8E178

Q33842644-016B1096-C227-442E-9C4C-49E6D2D8E458

Q33842644-1CED750F-CC47-44DD-9DD1-4755A8A73075

Q33842644-299DC90B-1333-4179-B956-72E0AE416058

Q33842644-29B08E90-B67E-43AA-8D5B-A7A620FB3AA6

Q33842644-2B1DAC25-C9A6-40DF-BA16-135013AACDA7

Q33842644-4B283F76-40CD-40E3-8C9E-11F572B29415

Q33842644-4FB227A2-A249-4AEB-96F9-ACF6D927D3A7

Q33842644-56978F4A-2024-4121-A092-7CE99A7183A6

Q33842644-5E0E4C51-082E-4B82-9EE2-129E5F3E2B2A

P304

Q33842644-73312228-37F3-4EA1-81D7-2B8C7934CE6A

P31

Q33842644-883C992C-D7EF-4EB9-AAA5-3B454F77C513

P356

Q33842644-3C8D5A07-7A07-4386-838B-595D71A24DDE

P407

Q33842644-E7351CED-30D3-4440-A317-AA72C11E7168

P433

Q33842644-4A740E8F-C696-460E-9CF3-47E2EC6D2EA1

P478

Q33842644-43A18098-DB0C-4781-887E-46440241B795

P50

Q33842644-19647879-6F28-4050-95BB-9CAF72BC8D56

Q33842644-941BDAFA-8517-4E4C-89D6-4E332CDA906F

Q33842644-AFF3B5BA-910E-4A75-9D68-B0691A5AF1F4

Q33842644-EA424963-FE5B-42C5-84F2-0243ECC3102A

Q33842644-FB6F8448-33E8-4356-A163-603119641669

P577

Q33842644-5CFDBA49-5319-4392-8444-F22146BB7FB9

P5875

Q33842644-C086931D-4B71-47F7-9FB0-468C9CEB8C49

P698

Q33842644-6F20824C-B2B6-4FF3-A9B0-E535F9BF7E23

P921

Q33842644-8579B24C-4316-4C41-9866-79AD431D879E

P932

Q33842644-C5AFE8BE-A061-4ADF-A911-498CB3840F03

P356

PNAS.0915133107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A defunctioning polymorphism i ...... o systemic lupus erythematosus

@en

P2093

Heather A Niederer

http://www.w3.org/2001/XMLSchema#string

J Anthony G Scott

http://www.w3.org/2001/XMLSchema#string

Kenneth G C Smith

http://www.w3.org/2001/XMLSchema#string

Lisa C Willcocks

http://www.w3.org/2001/XMLSchema#string

Norbert Peshu

http://www.w3.org/2001/XMLSchema#string

Paul A Lyons

http://www.w3.org/2001/XMLSchema#string

Wanling Yang

http://www.w3.org/2001/XMLSchema#string

Yu Lung Lau

http://www.w3.org/2001/XMLSchema#string

P2860

How malaria has affected the human genome and what human genetics can teach us about malaria

Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases

Meta-analysis in clinical trials

The 1982 revised criteria for the classification of systemic lupus erythematosus

Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.

Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection.

Immune inhibitory receptors.

Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais.

A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.

Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.

P304

7881-7885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0915133107

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N Williams

P577

2010-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43131012

http://www.w3.org/2001/XMLSchema#string

P698

20385827

http://www.w3.org/2001/XMLSchema#string

P921

P932

2867866

http://www.w3.org/2001/XMLSchema#string